A Prospective Case-crossover Study to Evaluate the Possible association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic anterior Ischemic Optic Neuropathy (NAION)
|Effective start/end date||4/1/13 → 12/31/15|
- Eli Lilly and Company
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.